LB-S&T-04 PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, MULTINATIONAL, PHASE 3 CLINICAL TRIAL OF THE PORE FORMING PROTEIN PRX302 FOR TARGETED TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.